Carboplatin and Pegylated Liposomal Doxorubicin Versus Carboplatin and Paclitaxel in Very Platinum-Sensitive Ovarian Cancer Patients: Results from a Subset Analysis of the CALYPSO Phase III GCIG Trial.

S. Mahner, W. Meier,A. Du Bois,C. Brown,D. Lorusso,A. Ferrero,J. Cretin,H. Havsteen,P. Bessette,L. Angleitner-Boubenizek,I. B. Vergote,P. A. Vasey,V. Gebski,B. Slama,J. Herrstedt,L. Kaizer, A. Georgoulopoulos,N. Reed,U. Wagner

Journal of clinical oncology（2011）

引用 79|浏览50
暂无评分
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要